Related Experiment Video
Updated: Jul 30, 2026

08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Thorotrast and the liver--revisited
1Texas Tech University Health Sciences Center, Amarillo 79106-1797, USA.
Journal of Toxicology. Clinical Toxicology
|January 1, 1997
Summary
Thorotrast (thorium dioxide) exposure can lead to serious health issues like liver angiosarcoma and bone marrow failure decades later. These delayed complications are linked to chronic alpha irradiation from the retained contrast agent.
Area of Science:
- Radiology
- Oncology
- Toxicology
Background:
- Thorotrast, a thorium dioxide colloid contrast agent, was used from 1928-1955.
- It deposits in the reticuloendothelial system and is retained long-term.

